Transitional Case Management Study

This study has been completed.
Sponsor:
Collaborators:
Connecticut State, Department of Mental Health and Addiction Services
National Development and Research Institutes, Inc.
University of Delaware
University of Kentucky
Information provided by:
University of California, Los Angeles
ClinicalTrials.gov Identifier:
NCT00264329
First received: December 8, 2005
Last updated: June 4, 2008
Last verified: June 2008
  Purpose

To address the issues involved in treatment participation by substance-abusing parolees, the CJ-DATS Transitional Case Management (TCM) study proposes to test a parole re-entry model that consists of (1) completion by the inmate of a strengths and goals assessment as part of discharge planning, (2) a telephone case conference call that includes the inmate and significant members of the inmate's aftercare plan (including the parole officer), and (3) strengths case management (for 12 weeks) in the community to promote treatment participation and support the client's access to needed services.


Condition Intervention Phase
Substance-Related Disorders
Other: Transitional Case Management Study
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Transitional Case Management Study

Further study details as provided by University of California, Los Angeles:

Primary Outcome Measures:
  • Treatment admission by three months following parole [ Time Frame: Three months ] [ Designated as safety issue: No ]
  • Treatment retention by three months following parole [ Time Frame: Three months ] [ Designated as safety issue: No ]
  • Drug use at nine months following parole [ Time Frame: Nine months ] [ Designated as safety issue: No ]
  • Recidivism at nine months following parole [ Time Frame: Nine months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Education and employment at nine months following parole [ Time Frame: Nine months ] [ Designated as safety issue: No ]
  • HIV risk behaviors at nine months following parole [ Time Frame: Nine months ] [ Designated as safety issue: No ]

Enrollment: 812
Study Start Date: November 2004
Study Completion Date: May 2008
Primary Completion Date: April 2006 (Final data collection date for primary outcome measure)
Intervention Details:
    Other: Transitional Case Management Study
    In an effort to address problems involved in parole re-entry, the Transitional Case Management (TCM) intervention tested a model of strengths-based case management consisting of (1) completion by the inmate of a strengths and goals assessment as part of discharge planning, (2) a telephone conference call that included the inmate and people central to the inmate's aftercare plan (including the parole officer), and (3) strengths case management for 12 weeks in the community to promote treatment participation and increase the client's access to needed services.
Detailed Description:

To address the issues involved in treatment participation by substance-abusing parolees, the CJ-DATS Transitional Case Management (TCM) study proposes to test a parole re-entry model that consists of (1) completion by the inmate of a strengths and goals assessment as part of discharge planning, (2) a telephone case conference call that includes the inmate and significant members of the inmate's aftercare plan (including the parole officer), and (3) strengths case management (for 12 weeks) in the community to promote treatment participation and support the client's access to needed services.

More specifically, the multi-site study will evaluate the effects of a strengths case-management intervention on community-based treatment/service admission, retention, and utilization among inmates released from supervised treatment programs. If the intervention is successful, its wider adoption would increase the likelihood that inmates enter and remain in community services.

The specific aims of this multi-site study are to:

  1. Increase the likelihood that offenders leaving prison (or other supervised setting) with a referral to community aftercare program services enroll in treatment.
  2. Increase the amount of time that such offenders participate in community treatment.
  3. Assist clients to get the services that they need during the first 12 weeks of return to the community.
  4. As a result of the above, reduce relapse and reoffending during and following treatment.
  5. Achieve the above results at a favorable cost-effectiveness ratio.
  6. Encourage closer collaboration between the treatment and criminal justice systems.

Study participants (200 at each site, 25% of will be women) will be recruited in prison (or other confined setting) from inmates who have a referral to community treatment. After informed consent and a baseline interview, they will be randomly assigned to one of two conditions: (1) the Transitional Case Management condition, and (2) the Standard Referral condition (i.e., usual transition/re-entry procedures used by the facility, including a referral to community treatment).

Individual-level outcomes will include (1) treatment admission and participation (based on data collected from programs), (2) drug use, criminal activity, and psychosocial functioning (based on telephone interviews conducted 3 months after the end of the intervention) and (3) recidivism (based on records collected 12 months after the end of the intervention). The study will also assess the impact of the intervention on organizational and system factors (based on information from the case manager, treatment staff, and criminal justice staff) and the cost effectiveness of the intervention.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Age 18 years or older
  • Participate in a treatment program within a correctional institution (prison, work release, community correctional facility)
  • Have a referral to a community-based substance abuse treatment program (as arranged by correctional staff or treatment staff)
  • Within about 3 months until release
  • Being released to the metropolitan area where case manager activities are being conducted

Exclusion Criteria:

  • Referral to formal case management services in the community (e.g., for offenders with co-occurring disorders)
  • Inability to provide informed consent (as determined by a set of questions about the consent process)
  • Registered sex offender (as determined by the institution)
  • Parole requirements that would prevent participation in the study (e.g., INS hold for deportation)
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00264329

Locations
United States, California
University of California, Los Angeles
Los Angeles, California, United States, 90025
United States, Connecticut
Connecticut Department of Mental Health and Addiction Services
Hartford, Connecticut, United States, 06134
United States, Kentucky
University of Kentucky
Lexington, Kentucky, United States, 40506
United States, New York
National Development and Research Institutes, Inc. (NDRI)
New York, New York, United States, 10048
Sponsors and Collaborators
University of California, Los Angeles
Connecticut State, Department of Mental Health and Addiction Services
National Development and Research Institutes, Inc.
University of Delaware
University of Kentucky
Investigators
Principal Investigator: Michael L Prendergast, Ph.D. University of California, Los Angeles
Study Director: Jerome Cartier, M.S. University of California, Los Angeles
  More Information

No publications provided

Responsible Party: Michael Prendergast/Principal Investigator, University of California, Los Angeles
ClinicalTrials.gov Identifier: NCT00264329     History of Changes
Other Study ID Numbers: U01DA16211
Study First Received: December 8, 2005
Last Updated: June 4, 2008
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Substance-Related Disorders
Mental Disorders

ClinicalTrials.gov processed this record on July 29, 2014